Correct stimulation of CD28H arms NK cells against tumor cells - Archive ouverte HAL
Article Dans Une Revue European Journal of Immunology Année : 2024

Correct stimulation of CD28H arms NK cells against tumor cells

Résumé

Tumor evasion has recently been associated with a novel member of the B7 family, HERV‐H LTR‐associating 2 (HHLA2), which is mostly overexpressed in PDL‐1 neg tumors. HHLA2 can either induce a costimulation signal when bound to CD28H or inhibit it by binding to KIR3DL3 on T‐ and NK cells. Given the broad distribution of CD28H expression on NK cells and its role, we compared two monoclonal antibodies targeting this novel NK‐cell engager in this study. We show that targeting CD28H at a specific epitope not only strongly activates Ca 2+ flux but also results in NK‐cell activation. CD28H‐activated NK cells further display increased cytotoxic activity against hematopoietic cell lines and bypass HHLA2 and HLA‐E inhibitory signals. Additionally, scRNA‐seq analysis of clear cell renal cancer cells revealed that HHLA2 + clear cell renal cancer cell tumors were infiltrated with CD28H + NK cells, which could be targeted by finely chosen anti‐CD28H Abs.
Fichier principal
Vignette du fichier
latest.pdf (913.66 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-04704026 , version 1 (06-01-2025)

Licence

Identifiants

Citer

Raphaëlle Leau, Pierre Duplouye, Virginie Huchet, Véronique Nerrière-Daguin, Bernard Martinet, et al.. Correct stimulation of CD28H arms NK cells against tumor cells. European Journal of Immunology, 2024, Online ahead of print. ⟨10.1002/eji.202350901⟩. ⟨hal-04704026⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

More